NO20080781L - GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer - Google Patents
GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommerInfo
- Publication number
- NO20080781L NO20080781L NO20080781A NO20080781A NO20080781L NO 20080781 L NO20080781 L NO 20080781L NO 20080781 A NO20080781 A NO 20080781A NO 20080781 A NO20080781 A NO 20080781A NO 20080781 L NO20080781 L NO 20080781L
- Authority
- NO
- Norway
- Prior art keywords
- glepp
- autoimmune
- treatment
- inhibitors
- inflammatory diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05106547 | 2005-07-15 | ||
| US70636505P | 2005-08-08 | 2005-08-08 | |
| PCT/EP2006/064288 WO2007009959A1 (en) | 2005-07-15 | 2006-07-14 | Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080781L true NO20080781L (no) | 2008-02-13 |
Family
ID=35423337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080781A NO20080781L (no) | 2005-07-15 | 2008-02-13 | GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20080207722A1 (sr) |
| EP (1) | EP1904048B1 (sr) |
| JP (1) | JP2009501197A (sr) |
| KR (1) | KR20080036084A (sr) |
| CN (1) | CN101282719A (sr) |
| AT (1) | ATE534380T1 (sr) |
| AU (1) | AU2006271682B2 (sr) |
| BR (1) | BRPI0613400A2 (sr) |
| CA (1) | CA2609929A1 (sr) |
| CY (1) | CY1112148T1 (sr) |
| DK (1) | DK1904048T3 (sr) |
| EA (1) | EA200800342A1 (sr) |
| ES (1) | ES2377881T3 (sr) |
| HR (1) | HRP20110875T1 (sr) |
| IL (1) | IL188735A (sr) |
| MX (1) | MX2008000665A (sr) |
| NO (1) | NO20080781L (sr) |
| PL (1) | PL1904048T3 (sr) |
| PT (1) | PT1904048E (sr) |
| RS (1) | RS52116B (sr) |
| SI (1) | SI1904048T1 (sr) |
| UA (1) | UA94049C2 (sr) |
| WO (1) | WO2007009959A1 (sr) |
| ZA (1) | ZA200710497B (sr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2564931T3 (es) * | 2009-07-30 | 2016-03-30 | Teva Pharmaceutical Industries Ltd. | Tratamiento de enfermedad de Crohn con laquinimod |
| WO2012149049A1 (en) * | 2011-04-26 | 2012-11-01 | Indiana University Research And Technology Corporation | Tyrosine phosphatase inhibitors and uses thereof to modulate the activity of enzymes involved in the pathology of mycobacterium tuberculosis |
| EP3394041A1 (en) * | 2015-12-22 | 2018-10-31 | Syngenta Participations AG | Microbiocidal oxadiazole derivatives |
| CN107936110B (zh) * | 2017-11-07 | 2021-06-22 | 潍坊医学院 | 突变基因Nasp在狼疮性模型小鼠自身免疫病发病中的作用及机制 |
| WO2021206787A1 (en) * | 2020-04-06 | 2021-10-14 | Purdue Research Foundation | Novel n-aryl oxamic acids |
| US20250332138A1 (en) * | 2022-01-27 | 2025-10-30 | Vivozon, Inc. | Pharmaceutical composition for preventing or treating mental disorder |
| CN118239851B (zh) * | 2024-03-20 | 2025-07-25 | 蚌埠医科大学 | 一种ptpro抑制剂的制备方法及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE82916B1 (en) | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
| EP0727406B1 (de) * | 1995-02-16 | 2001-09-05 | MERCK PATENT GmbH | Vinylenverbindungen und flüssigkristallines Medium |
| AU5347496A (en) * | 1995-04-21 | 1996-11-07 | Daiichi Pharmaceutical Co., Ltd. | Ethynylthiazole derivative |
| FR2762514B1 (fr) * | 1997-04-29 | 1999-10-22 | Sanofi Sa | Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation |
| WO2003032999A1 (en) | 2001-10-12 | 2003-04-24 | Warner-Lambert Company Llc | Alkyne matrix metalloproteinase inhibitors |
| CA2463615C (en) * | 2001-10-30 | 2011-07-26 | Applied Research Systems Ars Holding N.V. | Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| JP2003171305A (ja) * | 2001-11-30 | 2003-06-20 | Yunie:Kk | 糖尿病改善治療剤 |
| JP2005170790A (ja) | 2002-01-09 | 2005-06-30 | Ajinomoto Co Inc | N−アルキルスルフォニル置換アミド誘導体 |
| ATE510817T1 (de) * | 2002-01-29 | 2011-06-15 | Merck Serono Sa | Substituierte methylenamidderivate als modulatoren von proteintyrosinphosphatasen (ptps) |
| EP1603858A2 (en) | 2003-03-11 | 2005-12-14 | NeuroSearch A/S | Kcnq channel modulating compounds and their pharmaceutical use |
| AU2004261400A1 (en) * | 2003-07-21 | 2005-02-10 | Laboratoires Serono Sa | Alkynyl aryl carboxamides |
| WO2005007616A1 (en) | 2003-07-23 | 2005-01-27 | Warner-Lambert Company Llc | Diphenylamino ketone derivatives as mek inhibitors |
| AU2005231980B2 (en) * | 2004-04-07 | 2011-09-08 | Merck Serono Sa | 1,1'-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors |
-
2006
- 2006-07-14 AT AT06777795T patent/ATE534380T1/de active
- 2006-07-14 US US11/916,097 patent/US20080207722A1/en not_active Abandoned
- 2006-07-14 ZA ZA200710497A patent/ZA200710497B/xx unknown
- 2006-07-14 WO PCT/EP2006/064288 patent/WO2007009959A1/en not_active Ceased
- 2006-07-14 PL PL06777795T patent/PL1904048T3/pl unknown
- 2006-07-14 CA CA002609929A patent/CA2609929A1/en not_active Abandoned
- 2006-07-14 JP JP2008520891A patent/JP2009501197A/ja active Pending
- 2006-07-14 MX MX2008000665A patent/MX2008000665A/es active IP Right Grant
- 2006-07-14 ES ES06777795T patent/ES2377881T3/es active Active
- 2006-07-14 SI SI200631196T patent/SI1904048T1/sl unknown
- 2006-07-14 DK DK06777795.3T patent/DK1904048T3/da active
- 2006-07-14 EA EA200800342A patent/EA200800342A1/ru unknown
- 2006-07-14 KR KR1020087003525A patent/KR20080036084A/ko not_active Ceased
- 2006-07-14 RS RS20110580A patent/RS52116B/sr unknown
- 2006-07-14 UA UAA200800236A patent/UA94049C2/ru unknown
- 2006-07-14 EP EP06777795A patent/EP1904048B1/en active Active
- 2006-07-14 CN CNA2006800336726A patent/CN101282719A/zh active Pending
- 2006-07-14 BR BRPI0613400-9A patent/BRPI0613400A2/pt not_active IP Right Cessation
- 2006-07-14 HR HR20110875T patent/HRP20110875T1/hr unknown
- 2006-07-14 PT PT06777795T patent/PT1904048E/pt unknown
- 2006-07-14 AU AU2006271682A patent/AU2006271682B2/en not_active Expired - Fee Related
-
2008
- 2008-01-13 IL IL188735A patent/IL188735A/en not_active IP Right Cessation
- 2008-02-13 NO NO20080781A patent/NO20080781L/no not_active Application Discontinuation
-
2011
- 2011-12-14 CY CY20111101240T patent/CY1112148T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1904048T3 (da) | 2011-12-19 |
| WO2007009959A1 (en) | 2007-01-25 |
| EA200800342A1 (ru) | 2008-08-29 |
| EP1904048A1 (en) | 2008-04-02 |
| ES2377881T3 (es) | 2012-04-02 |
| KR20080036084A (ko) | 2008-04-24 |
| RS52116B (sr) | 2012-08-31 |
| CN101282719A (zh) | 2008-10-08 |
| US20080207722A1 (en) | 2008-08-28 |
| IL188735A0 (en) | 2008-12-29 |
| AU2006271682A1 (en) | 2007-01-25 |
| IL188735A (en) | 2012-07-31 |
| ATE534380T1 (de) | 2011-12-15 |
| PL1904048T3 (pl) | 2012-04-30 |
| CY1112148T1 (el) | 2015-11-04 |
| EP1904048B1 (en) | 2011-11-23 |
| ZA200710497B (en) | 2009-04-29 |
| MX2008000665A (es) | 2008-03-13 |
| JP2009501197A (ja) | 2009-01-15 |
| CA2609929A1 (en) | 2007-01-25 |
| AU2006271682B2 (en) | 2012-07-05 |
| HRP20110875T1 (hr) | 2011-12-31 |
| UA94049C2 (ru) | 2011-04-11 |
| BRPI0613400A2 (pt) | 2011-01-11 |
| SI1904048T1 (sl) | 2012-01-31 |
| PT1904048E (pt) | 2011-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| DK2024367T3 (da) | Tetrahydropyrrolopyrimidindioner og deres anvendelse som inhibitorer af human neutrofil elastase | |
| CY1108748T1 (el) | Χρηση αναστολεων της il-18 για την αντιμετωπιση και/η προληψη περιφερικων αγγειακων παθησεων | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| CY2016015I2 (el) | Αζετιδινες ως αναστολεις μεκ για τη θεραπευτικη αγωγη πολλαπλασιαστικων ασθενειων | |
| ATE416177T1 (de) | Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
| EA200700175A1 (ru) | Композиции и способы лечения воспалительных заболеваний | |
| DK1809280T3 (da) | Mitotiske kinesininhibitorer og fremgangsmåder til anvendelse deraf | |
| ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
| NO20082120L (no) | Behandling og forebyggelse av mikroangiopati | |
| MX2010000098A (es) | Derivados de guanina policiclicos y sus metodos de uso. | |
| JO3676B1 (ar) | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| EP1965827A4 (en) | TREATMENT OF CONDITIONS RELATED TO DEMYELINATION | |
| CY1117251T1 (el) | Μεθοδοι θεραπευτικης αντιμετωπισης της σκληροδερμιας | |
| EP2046368A4 (en) | ANTI-COCAINE COMPOSITIONS AND TREATMENT | |
| IL188735A0 (en) | Use of glepp-1 inhibitor for the menufacture of a medicament for treament of an autoimmune and/or inflamatory disorder | |
| MX2009005550A (es) | Inhibidores de fosfatasa de proteina tirosina para la promocion de la hipertrofia cardiaca fisiologica. | |
| EA200801244A1 (ru) | Применение sdf-1 для лечения и/или профилактики неврологических заболеваний | |
| ATE481392T1 (de) | Benzimidazolderivate zur behandlung entzündlicher erkrankungen | |
| UA110918C2 (uk) | Інгібітори протеїнфосфатази-1 та їх застосування | |
| ATE552888T1 (de) | Elastasehemmer bei leukämie | |
| DE602004028497D1 (de) | Verwendung von ciclesonid zur behandlung von entzündlichen darmerkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |